Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells.
about
Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of ImmunotherapyCancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant StateDormancy of metastatic melanomaTumor vaccine composed of C-class CpG oligodeoxynucleotides and irradiated tumor cells induces long-term antitumor immunity.Bone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patientsERK1/2 and p38α/β signaling in tumor cell quiescence: opportunities to control dormant residual disease.T cell-mediated immunotherapy of metastases: state of the art in 2005.Microenvironments dictating tumor cell dormancyCancer vaccines and tumor dormancy: a long-term struggle between host antitumor immunity and persistent cancer cells?Regulation of tumor cell dormancy by tissue microenvironments and autophagy.Models, mechanisms and clinical evidence for cancer dormancy.Immune-mediated dormancy: an equilibrium with cancer.Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function.Adoptive immunotherapy of metastatic breast cancer: present and future.Complete remission of cancer in late-stage disease by radiation and transfer of allogeneic MHC-matched immune T cells: lessons from GvL studies in animals.Cancer-immune equilibrium: questions unansweredTuning cancer fate: the unremitting role of host immunity.Decoding melanoma metastasisAntitumor T cell responses in bladder cancer are directed against a limited set of antigens and are modulated by regulatory T cells and routine treatment approaches.Metronomic chemotherapy for non-metastatic triple negative breast cancer: Selection is the key.Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies.Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation.
P2860
Q26745444-31EC220E-EB76-434A-A0D0-C53832607619Q26782573-F1CFDD62-2AE0-41BD-A0A1-0455170CEDB8Q33649569-B5BC4A73-8CDE-45FE-8796-D120A0D68AAEQ33690978-71831E38-E49B-47F6-A695-637A99068CB9Q34547042-C381C21F-F773-443A-B1E9-9877839E54F1Q35579435-EC4B971C-508F-42F1-B276-C6C7AD849AEAQ36210864-5A58A959-7657-4C34-A4C2-929F0F31B117Q36450759-70C7F242-6909-4E8E-B318-D657E4F4873EQ36690273-8A7C8B7A-ED8F-4F28-B670-6B8F41E4ED43Q36836555-FDF6435D-41FD-4F0B-9D74-AD6C22289D72Q36844303-F3D71DE5-7AFA-43B9-BC1A-43DCC98D65A1Q37178663-C3B8DE5F-42AE-4EC8-90F3-71159CB60B50Q38161930-73E0D244-E240-4DD8-B28C-E061B4420152Q38171325-B9EEE16F-C490-428C-B280-6292716C5EBEQ38194489-DA2B4DE3-1AAC-41E9-BEE6-1A6E084D31C4Q38366247-253D1376-6C78-4C4E-997A-41B3FB13057CQ39239026-EB111AEC-F4D9-4AF1-94CA-3253151F5048Q42575715-B3B83DC1-407D-426A-86A8-7CECA311CB9BQ43498496-B3387090-FD38-4A75-9A85-52D0BB500C47Q47103586-8E939B6C-0FF2-4ECF-9EBD-98BF0C2EEFFFQ48308048-C6C3F879-4B02-47E5-A8A5-3C2678C50190Q52564628-A203664C-9A47-42B8-9925-0E6936A6A028
P2860
Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells.
@en
type
label
Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells.
@en
prefLabel
Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells.
@en
P2093
P2860
P1433
P1476
Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells
@en
P2093
Jochen Schwendemann
Philipp Beckhove
Volker Schirrmacher
P2860
P304
P356
10.1111/J.1365-2567.2005.02163.X
P577
2005-07-01T00:00:00Z